SciVision Biotech Inc. (TPE:1786)
56.80
-0.80 (-1.39%)
May 8, 2026, 1:30 PM CST
SciVision Biotech Market Cap
SciVision Biotech has a market cap or net worth of 4.25 billion as of May 8, 2026. Its market cap has decreased by -34.28% in one year.
Market Cap
4.25B
Enterprise Value
3.81B
Revenue
886.62M
Ranking
n/a
PE Ratio
26.07
Stock Price
56.80
Market Cap Chart
Since December 29, 2010, SciVision Biotech's market cap has increased from 1.23B to 4.25B, an increase of 245.97%. That is a compound annual growth rate of 8.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 4.25B | -18.91% |
| Dec 31, 2025 | 5.24B | -29.80% |
| Dec 31, 2024 | 7.47B | 42.10% |
| Dec 29, 2023 | 5.25B | 46.46% |
| Dec 30, 2022 | 3.59B | 9.27% |
| Dec 30, 2021 | 3.28B | -12.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioteque | 8.11B |
| Medeon Biodesign | 8.03B |
| Formosa Optical Technology | 5.84B |
| Pacific Hospital Supply | 5.79B |
| St.Shine Optical | 5.17B |
| Bionime | 3.96B |
| Maxigen Biotech | 3.53B |
| Nang Kuang Pharmaceutical | 3.42B |